Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat

Mohamed A. Saleh, Erika I. Boesen, Jennifer S. Pollock, Virginia J. Savin, David M. Pollock

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Endothelin (ET) 1 is a potent vasoactive peptide implicated in the pathogenesis of hypertension and renal disease. The aim of the current study was to test the hypotheses that ET-1 increases albumin permeability of glomeruli isolated from normal rats and that chronic ET-1 infusion will increase glomerular permeability and inflammation independent of blood pressure. Glomerular permeability to albumin was determined from the change in glomerular volume induced by exposing isolated glomeruli to oncotic gradients. Incubation of glomeruli taken from normal rats with ET-1 at a concentration that did not produce direct glomerular contraction (1 nmol/L) significantly increased glomerular permeability to albumin, reaching a maximum after 4 hours. Chronic ET-1 infusion for 2 weeks in Sprague-Dawley rats significantly increased glomerular permeability to albumin and nephrin excretion rate, effects that were attenuated in rats given an ETA receptor antagonist (ABT-627, 5 mg/kg per day). Urinary protein and albumin excretion and mean arterial pressure (telemetry) were not changed by ET-1 infusion. Acute incubation of glomeruli isolated from ET-1-infused rats with the selective ETA antagonist significantly reduced glomerular permeability to albumin, an effect not observed with acute treatment with a selective ETB antagonist. Chronic ET-1 infusion increased glomerular and plasma soluble intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 and elevated the number of macrophages and lymphocytes in renal cortices (ED-1 and CD3-positive staining, respectively). These effects were all attenuated in rats given an ETA selective antagonist. These data support the hypothesis that ET-1 directly increases glomerular permeability to albumin and renal inflammation via ETA receptor activation independent of changes in arterial pressure.

Original languageEnglish (US)
Pages (from-to)942-949
Number of pages8
JournalHypertension
Volume56
Issue number5
DOIs
StatePublished - Nov 1 2010

Fingerprint

Endothelin-1
Permeability
Blood Pressure
Inflammation
Albumins
Arterial Pressure
Kidney
Telemetry
Renal Hypertension
Chemokine CCL2
Lymphocyte Count
Intercellular Adhesion Molecule-1
Sprague Dawley Rats
Macrophages
Staining and Labeling
Peptides

Keywords

  • intercellular adhesion molecule
  • kidney
  • macrophage
  • monocyte chemotactic protein
  • rat

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. / Saleh, Mohamed A.; Boesen, Erika I.; Pollock, Jennifer S.; Savin, Virginia J.; Pollock, David M.

In: Hypertension, Vol. 56, No. 5, 01.11.2010, p. 942-949.

Research output: Contribution to journalArticle

Saleh, Mohamed A. ; Boesen, Erika I. ; Pollock, Jennifer S. ; Savin, Virginia J. ; Pollock, David M. / Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat. In: Hypertension. 2010 ; Vol. 56, No. 5. pp. 942-949.
@article{28dd3a8132b646a593ce14aea487e885,
title = "Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat",
abstract = "Endothelin (ET) 1 is a potent vasoactive peptide implicated in the pathogenesis of hypertension and renal disease. The aim of the current study was to test the hypotheses that ET-1 increases albumin permeability of glomeruli isolated from normal rats and that chronic ET-1 infusion will increase glomerular permeability and inflammation independent of blood pressure. Glomerular permeability to albumin was determined from the change in glomerular volume induced by exposing isolated glomeruli to oncotic gradients. Incubation of glomeruli taken from normal rats with ET-1 at a concentration that did not produce direct glomerular contraction (1 nmol/L) significantly increased glomerular permeability to albumin, reaching a maximum after 4 hours. Chronic ET-1 infusion for 2 weeks in Sprague-Dawley rats significantly increased glomerular permeability to albumin and nephrin excretion rate, effects that were attenuated in rats given an ETA receptor antagonist (ABT-627, 5 mg/kg per day). Urinary protein and albumin excretion and mean arterial pressure (telemetry) were not changed by ET-1 infusion. Acute incubation of glomeruli isolated from ET-1-infused rats with the selective ETA antagonist significantly reduced glomerular permeability to albumin, an effect not observed with acute treatment with a selective ETB antagonist. Chronic ET-1 infusion increased glomerular and plasma soluble intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 and elevated the number of macrophages and lymphocytes in renal cortices (ED-1 and CD3-positive staining, respectively). These effects were all attenuated in rats given an ETA selective antagonist. These data support the hypothesis that ET-1 directly increases glomerular permeability to albumin and renal inflammation via ETA receptor activation independent of changes in arterial pressure.",
keywords = "intercellular adhesion molecule, kidney, macrophage, monocyte chemotactic protein, rat",
author = "Saleh, {Mohamed A.} and Boesen, {Erika I.} and Pollock, {Jennifer S.} and Savin, {Virginia J.} and Pollock, {David M.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.110.156570",
language = "English (US)",
volume = "56",
pages = "942--949",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat

AU - Saleh, Mohamed A.

AU - Boesen, Erika I.

AU - Pollock, Jennifer S.

AU - Savin, Virginia J.

AU - Pollock, David M.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - Endothelin (ET) 1 is a potent vasoactive peptide implicated in the pathogenesis of hypertension and renal disease. The aim of the current study was to test the hypotheses that ET-1 increases albumin permeability of glomeruli isolated from normal rats and that chronic ET-1 infusion will increase glomerular permeability and inflammation independent of blood pressure. Glomerular permeability to albumin was determined from the change in glomerular volume induced by exposing isolated glomeruli to oncotic gradients. Incubation of glomeruli taken from normal rats with ET-1 at a concentration that did not produce direct glomerular contraction (1 nmol/L) significantly increased glomerular permeability to albumin, reaching a maximum after 4 hours. Chronic ET-1 infusion for 2 weeks in Sprague-Dawley rats significantly increased glomerular permeability to albumin and nephrin excretion rate, effects that were attenuated in rats given an ETA receptor antagonist (ABT-627, 5 mg/kg per day). Urinary protein and albumin excretion and mean arterial pressure (telemetry) were not changed by ET-1 infusion. Acute incubation of glomeruli isolated from ET-1-infused rats with the selective ETA antagonist significantly reduced glomerular permeability to albumin, an effect not observed with acute treatment with a selective ETB antagonist. Chronic ET-1 infusion increased glomerular and plasma soluble intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 and elevated the number of macrophages and lymphocytes in renal cortices (ED-1 and CD3-positive staining, respectively). These effects were all attenuated in rats given an ETA selective antagonist. These data support the hypothesis that ET-1 directly increases glomerular permeability to albumin and renal inflammation via ETA receptor activation independent of changes in arterial pressure.

AB - Endothelin (ET) 1 is a potent vasoactive peptide implicated in the pathogenesis of hypertension and renal disease. The aim of the current study was to test the hypotheses that ET-1 increases albumin permeability of glomeruli isolated from normal rats and that chronic ET-1 infusion will increase glomerular permeability and inflammation independent of blood pressure. Glomerular permeability to albumin was determined from the change in glomerular volume induced by exposing isolated glomeruli to oncotic gradients. Incubation of glomeruli taken from normal rats with ET-1 at a concentration that did not produce direct glomerular contraction (1 nmol/L) significantly increased glomerular permeability to albumin, reaching a maximum after 4 hours. Chronic ET-1 infusion for 2 weeks in Sprague-Dawley rats significantly increased glomerular permeability to albumin and nephrin excretion rate, effects that were attenuated in rats given an ETA receptor antagonist (ABT-627, 5 mg/kg per day). Urinary protein and albumin excretion and mean arterial pressure (telemetry) were not changed by ET-1 infusion. Acute incubation of glomeruli isolated from ET-1-infused rats with the selective ETA antagonist significantly reduced glomerular permeability to albumin, an effect not observed with acute treatment with a selective ETB antagonist. Chronic ET-1 infusion increased glomerular and plasma soluble intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 and elevated the number of macrophages and lymphocytes in renal cortices (ED-1 and CD3-positive staining, respectively). These effects were all attenuated in rats given an ETA selective antagonist. These data support the hypothesis that ET-1 directly increases glomerular permeability to albumin and renal inflammation via ETA receptor activation independent of changes in arterial pressure.

KW - intercellular adhesion molecule

KW - kidney

KW - macrophage

KW - monocyte chemotactic protein

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=78149277201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149277201&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.110.156570

DO - 10.1161/HYPERTENSIONAHA.110.156570

M3 - Article

C2 - 20823379

AN - SCOPUS:78149277201

VL - 56

SP - 942

EP - 949

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -